Light Therapy in End Stage Kidney Disease

StatusCompleted
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Trial completed Show 5 more changesShow less
    • Final enrollment: 8 participants (planned 60)
    • Study completion date changed from estimate of Oct 1, 2026 to Jul 7, 2026
    • Primary completion date: Jul 1, 2026 to Jul 7, 2026
    • Eligibility criteria expanded, about 8 words
    • Study description expanded, about 4 words
  2. Minor Primary completion moved earlier from Aug 1, 2026 to Jul 1, 2026v10
  3. Minor Trial status changed: Recruiting → Active, Not Recruiting
    • Primary completion pushed from Jun 1, 2026 to Aug 1, 2026
    • Study completion pushed from Aug 1, 2026 to Oct 1, 2026
    • Site details revised
    v9
  4. Minor Re-verified, no change to tracked fieldsv8
  5. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date: Jan 1, 2026 to Feb 1, 2026
    • Study sites: 0 to 1
    v7
Show 5 earlier versionsHide 5 earlier versions
  1. Notable Primary completion date: Jun 1, 2025 to Jun 1, 2026
    • Start date: Jan 1, 2025 to Jan 1, 2026
    • Study completion date: Aug 1, 2025 to Aug 1, 2026
    v6
  2. Notable Start date: Oct 1, 2024 to Jan 1, 2025
    • Primary completion date: Mar 1, 2025 to Jun 1, 2025
    • Study completion date: Mar 1, 2025 to Aug 1, 2025
    v5
  3. Notable Start date: Aug 1, 2024 to Oct 1, 2024
    • Primary completion date: Dec 1, 2024 to Mar 1, 2025
    v4
  4. Notable Start date: Apr 1, 2024 to Aug 1, 2024
    • Primary completion date: Nov 1, 2024 to Dec 1, 2024
    v3
  5. Minor Eligibility criteria expanded, about 3 wordsv2
  1. Minor Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to test light therapy in patients with end stage kidney disease who are receiving hemodialysis. The main aim is to determine if light therapy decreases fatigue severity. Participants will receive light therapy using special glasses for one hour during the dialysis sessions for four weeks of treatment.
Trial Details
NCT Number NCT06310161
Lead Sponsor University of Pennsylvania
Conditions
(from sponsor)
End Stage Renal Disease
Related terms Kidney Failure, Chronic
Enrollment 8 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov